The COMFORTage Project at Ace Alzheimer Center Barcelona

Last updated: June 12, 2025
Sponsor: Fundació ACE Institut Català de Neurociències Aplicades
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Mild Cognitive Impairment

Dementia

Memory Problems

Treatment

Cognitive and functional stimulation using digital platforms

Clinical Study ID

NCT07031167
comfortage_ace_1
  • Ages 60-85
  • All Genders

Study Summary

The COMFORTage study at Ace Alzheimer Center Barcelona is investigating whether a personalized cognitive and functional stimulation program can help slow cognitive decline in individuals diagnosed with mild cognitive impairment (MCI) or mild Alzheimer's disease (AD) dementia.

The study involves 100 participants aged 60 to 85, who are randomly assigned to one of two groups. The active group receives weekly in-person sessions for one year, featuring individualized cognitive and physical training through digital platforms developed by the COMFORTage project. The control group does not participate in the training but undergoes the same schedule of health assessments and monitoring.

All participants are followed for a total of two years. Throughout the study, researchers collect comprehensive clinical, neuropsychological, and biological data. This includes cognitive assessments, magnetic resonance imaging (MRI) brain scans, blood and cerebrospinal fluid (CSF) samples, and genetic testing. In addition, participants complete spontaneous speech recordings from home every 3-4 months using a dedicated mobile application.

The primary objective is to determine whether the stimulation program more effectively preserves memory and cognitive function compared to no intervention. The study also evaluates its impact on physical and emotional well-being, daily functioning, and quality of life. Insights from the trial will contribute to the development of an artificial intelligence (AI)-powered digital health platform aimed at delivering personalized care for individuals living with dementia.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age between 60 and 85 years.

  • Diagnosis of MCI based on Petersen criteria with a CDR score of 0.5.

  • Diagnosis of mild AD dementia according to National Institute on Aging-Alzheimer'sAssociation (NIA-AA) criteria with a CDR score of 1.

  • Proficiency in using digital tools such as mobile apps, tablets, or computers.

  • Ability and willingness to attend regular in-person sessions at Ace Alzheimer CenterBarcelona.

  • Provided written informed consent after receiving a full explanation of the study.

Exclusion

Exclusion Criteria:

  • History of traumatic brain injury.

  • Diagnosis of severe depression.

  • History of stroke or brain tumors.

  • Presence of significant uncorrected visual or auditory impairments.

  • Lack of access to a digital device or internet connection.

  • Inability to participate in regular in-person sessions at the study site.

  • Any medical condition that may confound cognitive assessment or limit participation.

Study Design

Total Participants: 100
Treatment Group(s): 1
Primary Treatment: Cognitive and functional stimulation using digital platforms
Phase:
Study Start date:
July 01, 2025
Estimated Completion Date:
July 01, 2028

Connect with a study center

  • Ace Alzheimer Centre Barcelona (Fundació ACE)

    Barcelona, 08028
    Spain

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.